Download FREE Report Sample
Download Free sampleEperisone is a central muscle relaxant.Acting on the spinal cord and vascular smooth muscle, it can reduce the sensitivity of muscle spindle by inhibiting the spinal cord reflex, inhibiting the spontaneous impulse of the myomotor neurons, and thus relieving the tension of skeletal muscle.And through the expansion of blood vessels and improve blood circulation, from many aspects to block muscle tension hyperactivity ? circulation disorder ? muscle pain ? muscle tension hyperactivity this kind of skeletal muscle tension vicious circle.
Eperisone Market contains market size and forecasts of Eperisone in global, including the following market information:
Global Eperisone Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Eperisone Market Sales, 2017-2022, 2023-2028, (KG)
Global top five Eperisone companies in 2021 (%)
The global Eperisone market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Particles Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Eperisone include Navipharm, Daewon, Hanmi, Eisai, Bracco, Zambon, Hunan Yada Pharmaceutical and Qingdao Guohai Biopharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Eperisone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eperisone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Eperisone Market Segment Percentages, by Type, 2021 (%)
Particles
Tablets
Global Eperisone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Eperisone Market Segment Percentages, by Application, 2021 (%)
Neck Shoulder Wrist Syndrome
Shoulder Periarthritis
Lumbar Pains
Spastic Paralysis
Musculoskeletal Pain
Systemic Traumatic Pain
Other
Global Eperisone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)
Global Eperisone Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Eperisone revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Eperisone revenues share in global market, 2021 (%)
Key companies Eperisone sales in global market, 2017-2022 (Estimated), (KG)
Key companies Eperisone sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Navipharm
Daewon
Hanmi
Eisai
Bracco
Zambon
Hunan Yada Pharmaceutical
Qingdao Guohai Biopharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy